Adenoviral gene transfer in bovine adrenomedullary and murine pheochromocytoma cells: potential clinical and therapeutic relevance.
Recombinant adenoviruses (rAd) have been widely used as gene transfer vectors both in the laboratory and in human clinical trials. In the present study, we investigated the effects of adenoviral-mediated gene transfer in primary bovine adrenal chromaffin cells (BACC) and a murine pheochromocytoma cell line (MPC). Cells were infected with one of three nonreplicating E1/E3-deleted (E1(-)/E3(-)) rAd vectors: Ad.GFP, expressing a green fluorescent protein (GFP); Ad.null, expressing no transgene; or Ad.C2.TK, expressing the herpes simplex virus-1 thymidine kinase gene (TK). Forty-eight hours after exposure to Ad.GFP, the percentage of GFP-expressing BACC ranged from 23.5-97% in a dose-dependent manner and similarly from 1.06-84.4% in the MPC, indicating that adrenomedullary cells are a potentially valuable target for adenoviral-mediated gene transfer. Ultrastructural analysis, however, revealed profound changes in the nucleus and mitochondria of cells infected with rAd. Furthermore, infection of BACC with Ad.null was accompanied by a time- and dose-dependent decrease in cell survival due to the vector alone. Specific whole-cell norepinephrine uptake was also decreased in a time- and dose-dependent fashion in BACC. Infection of MPC cells with the Ad.C2.TK vector sensitized them to the cytotoxic effect of the antiviral drug ganciclovir, in direct proportion to the fraction of cells infected with the virus. We conclude that rAd may alter the structural and functional integrity of adrenomedullary cells, potentially interfering with the normal stress response. At the same time, in light of their ability to effectively deliver and express genes in pheochromocytoma cells, they may be applicable to the gene therapy of adrenomedullary tumors.
Alesci
Salvatore
S
Clinical Neuroendocrinology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA.
Perera
Shiromi M
SM
Lai
Edwin W
EW
Kukura
Christina
C
Abu-Asab
Mones
M
Tsokos
Maria
M
Morris
John C
JC
Pacak
Karel
K
D000256:Adenoviridae / Q000235:genetics*; D000310:Adrenal Gland Neoplasms / Q000473:pathology / Q000628:therapy*; D000818:Animals; D000998:Antiviral Agents; D002417:Cattle; D045744:Cell Line, Tumor; D002470:Cell Survival; D019439:Chromaffin Cells / Q000166:cytology / Q000502:physiology* / Q000648:ultrastructure; D015774:Ganciclovir; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D018259:Herpesvirus 1, Human / Q000235:genetics; D051379:Mice; D018345:Mice, Knockout; D008854:Microscopy, Electron; D009638:Norepinephrine / Q000493:pharmacokinetics; D010673:Pheochromocytoma / Q000473:pathology / Q000628:therapy*; D013937:Thymidine Kinase / Q000235:genetics; D019076:Transgenes / Q000235:genetics; D014316:Tritium
D000998:Antiviral Agents; D014316:Tritium; D013937:Thymidine Kinase; D015774:Ganciclovir; D009638:Norepinephrine